Evaluation of the combined application of ethanol-fixed and formaldehyde-fixed neutrophil substrates for identifying atypical perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease

Clinical and Vaccine Immunology

Volumn 16, Issue 4, 2009, Pages 464-470

  Papp, Maria ^a,c   Altorjay, Istvan ^a   Lakos, Gabriella ^b   Tumpek, Judit ^b   Sipka, Sandor ^b   Dinya, Tamas ^c   Palatka, Karoly ^a   Veres, Gabor ^d   Udvardy, Miklos ^a   Lakatos, Peter Laszlo ^e  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Division of Clinical Immunology   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d 1st Department of Pediatrics   (Hungary)

^e SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CATHEPSIN G; ELASTASE; FORMALDEHYDE; LACTOFERRIN; LYSOZYME; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PERINUCLEAR ANTINEUTROPHIL CYTOPLASMIC ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHANOL; FEMALE; FIXATIVES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FORMALDEHYDE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; NEUTROPHILS; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TISSUE FIXATION;

EID: 64549131688     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00002-09     Document Type: Article

References (32)

1. Billing, P., S. Tahir, B. Calfin, G. Gagne, L. Cobb, S. Targan, and A. Vidrich. 1995. Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies. Am. J. Pathol. 147: 979-987.
2. Bossuyt, X. 2006. Serologic markers in inflammatory bowel disease. Clin. Chem. 52:171-181.
3. Cambridge, G., D. S. Rampton, T. R. Stevens, D. A. McCarthy, M. Kamm, and B. Leaker. 1992. Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 33:668-674.
4. Chowdhury, S. M., V. Broomhead, G. P. Spickett, and R. Wilkinson. 1999. Pitfalls of formalin fixation for determination of antineutrophil cytoplasmic antibodies. J. Clin. Pathol. 52:475-477.
5. Gasche, C., J. Scholmerich, J. Brynskov, G. D'Haens, S. B. Hanauer, E. J. Irvine, D. P. Jewell, D. Rachmilewitz, D. B. Sachar, W. J. Sandborn, and L. R. Sutherland. 2000. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm. Bowel Dis. 6:8-15.
6. Joossens, S., M. Daperno, Z. Shums, K Van Steen, J. A. Goeken, C. Trapani, G. L. Norman, G. Godefridis, G. Claessens, A. Pera, M. Pierik, S. Vermeire, P. Rutgeerts, and X. Bossuyt. 2004. Interassay and interobserver variability in the detection of anti-neutrophil cytoplasmic antibodies in patients with ulcerative colitis. Clin. Chem. 50:1422-1425.
7. Klebl, F. H., F. Bataille, C. R. Bertea, H. Herfarth, F. Hofstadter, J. Scholmerich, and G. Rogler. 2003. Association of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies with Vienna classification subtypes of Crohn's disease. Inflamm. Bowel Dis. 9:302-307.
8. Koutroubakis, I. E., E. Petinaki, I. A. Mouzas, I. G. Vlachonikolis, E. Anagnostopoulou, E. Castanas, A. N. Maniatis, and E. A. Kouroumalis. 2001. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am. J. Gastroenterol. 96:449-454.
9. Lee, S. S., J. W. Lawton, and W. Chak. 1991. Distinction between antinuclearv antibody and P-ANCA. J. Clin. Pathol. 44:962-963.
10. Lennard-Jones, J. E. 1989. Classification of inflammatory bowel disease. Scand. J. Gastroenterol. Suppl. 170:2-6.
11. Linskens, R. K., R. C. Mallant-Hent, Z. M. Groothuismink, L. E. Bakker-Jonges, J. P. van de Merwe, H. Hooijkaas, B. M. von Blomberg, and S. G. Meuwissen. 2002. Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods. Eur. J. Gastroenterol. Hepatol. 14: 1013-1018.
12. Papp, M., G. L. Norman, I. Altorjay, and P. L. Lakatos. 2007. Utility of serological markers in inflammatory bowel diseases: gadget or magic? World J. Gastroenterol. 13:2028-2036.
13. Papp, M., I. Altorjay, G. L. Norman, Z. Shums, K. Palatka, Z. Vitalis, I. Foldi, G. Lakos, J. Tumpek, M. L. Udvardy, J. Harsfalvi, S. Fischer, L. Lakatos, A. Kovacs, L. Bene, T. Molnar, Z. Tulassay, P. Miheller, G. Veres, J. Papp, and L. P. Lakatos. 2007. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. Inflamm. Bowel Dis. 13:984-992.
14. Peeters, M., S. Joossens, S. Vermeire, R. Vlietinck, X. Bossuyt, and P. R Rutgeerts. 2001. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am. J. Gastroenterol. 96:730-734.
15. Podolsky, D. K. 2002. Inflammatory bowel disease. N. Engl. J. Med. 347: 417-429.
16. Quinton, J. F., B. Sendid, D. Reumaux, P. Duthilleul, A. Cortot, B. Grandbastien, G. Charrier, S. R. Targan, J. F. Colombel, and D. Poulain. 1998. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 42:788-791.
17. Radice, A., M. Vecchi, M. B. Bianchi, and R. A. Sinico. 2000. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives. Clin. Exp. Rheumatol. 18:707-712.
18. Roozendaal, C., M. H. Zhao, G. Horst, C. M. Lockwood, J. H. Kleibeuker, P. C. Limburg, G. F. Nelis, and C. G. Kallenberg. 1998. Catalase and α-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD). Clin. Exp. Immunol. 112:10-16.
19. Roozendaal, C., G. Horst, K. Pogany, A. W. van Milligen de Wit, J. H. Kleibeuker, E. B. Haagsma, P. C. Limburg, and C. G. Kallenberg. 1998.
20. Prevalence and clinical significance of anti-lactoferrin autoantibodies in inflammatory bowel diseases and primary sclerosing cholangitis. Adv. Exp. Med. Biol. 443:313-319.
21. Sandborn, W. J., C. J. Landers, W. J. Tremaine, and S. R. Targan. 1995. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after
22. Savige, J., B. Paspaliaris, R. Silvestrini, D. Davies, T. Nikoloutsopoulos, A. Sturgess, J. Neil, W. Pollock, K. Dunster, and M. Hendle. 1998. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies. J. Clin. Pathol. 51:568-575.
23. Savige, J., D. Gillis, E. Benson, D. Davies, V. Esnault, R. J. Falk, E. C. Hagen, D. Jayne, J. C. Jennette, B. Paspaliaris, W. Pollock, C. Pusey, C. O. Savage, R. Silvestrini, F. van der Woude, J. Wieslander, and A. Wiik. 1999. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am. J. Clin. Pathol. 111:507-513.
24. Savige, J., W. Dimech, M. Fritzler, J. Goeken, E. C. Hagen, J. C. Jennette, R. McEvoy, C. Pusey, W. Pollock, M. Trevisin, A. Wiik, and R. Wong for the International Group for Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). 2003. Addendum to the international consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. Am. J. Clin. Pathol. 120:312-318.
25. Sobajima, J., S. Ozaki, F. Osakada, H. Uesugi, H. Shirakawa, M. Yoshida, and K. Nakao. 1997. Novel autoantigens of perinuclear anti-neutrophil cy-toplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2. Clin. Exp. Immunol. 107:135-140.
26. Terjung, B., U. Spengler, T. Sauerbruch, and H. J. Worman. 2000. "Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines. Gastroenterology 119:310-322.
27. Terjung, B., and H. J. Worman. 2001. Anti-neutrophil antibodies in primary sclerosing cholangitis. 2001. Best Pract. Res. Clin. Gastroenterol. 15:629-642.
28. Terjung, B., H. J. Worman, V. Herzog, T. Sauerbruch, and U. Spengler. 2001. Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy. Clin. Exp. Immunol. 126:37-46.
29. Terjung, B., F. Bogsch, R. Klein, J. Sohne, C. Reichel, J. C. Wasmuth, U. Beuers, T. Sauerbruch, and U. Spengler. 2004. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC-and multivariate regression analysis. Eur. J. Med. Res. 9:439-448.
30. Vasiliauskas, E. A., S. E. Plevy, C. J. Landers, S. W. Binder, D. M. Ferguson, H. Yang, J. I. Rotter, A. Vidrich, and S. R. Targan. 1996. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology 110:1810-1819.
31. Vasiliauskas, E. A., L. Y. Kam, L. C. Karp, J. Gaiennie, H. Yang, and S. R. Targan. 2000. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 47:487-496.
32. Walmsley, R. S., M. H. Zhao, M. I. Hamilton, A. Brownlee, P. Chapman, R. E. Pounder, A. J. Wakefield, and C. M. Lockwood. 1997. Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease. Gut 40:105-109.